These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16697091)

  • 1. Immunization against Japanese encephalitis in China: a policy analysis.
    Liu W; Clemens JD; Yang JY; Xu ZY
    Vaccine; 2006 Jun; 24(24):5178-82. PubMed ID: 16697091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China.
    Yin Z; Beeler Asay GR; Zhang L; Li Y; Zuo S; Hutin YJ; Ning G; Sandhu HS; Cairns L; Luo H;
    Vaccine; 2012 Aug; 30(37):5569-77. PubMed ID: 22698453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia.
    Liu W; Clemens JD; Kari K; Xu ZY
    Vaccine; 2008 Aug; 26(35):4456-60. PubMed ID: 18602436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia.
    Touch S; Suraratdecha C; Samnang C; Heng S; Gazley L; Huch C; Sovann L; Chhay CS; Soeung SC
    Vaccine; 2010 Jun; 28(29):4593-9. PubMed ID: 20470803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological characteristics and related influencing factors on Japanese encephalitis in Hainan Province].
    Pan XH; Sun LY; Wang CL; Zhu J; Fu ZW; Zeng ZC; Zeng XX; Yan XJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):471-4. PubMed ID: 19799143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric live attenuated vaccine against Japanese encephalitis.
    Jones T
    Expert Rev Vaccines; 2004 Jun; 3(3):243-8. PubMed ID: 15176941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
    Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD
    Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
    Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
    Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
    Vaccine; 2007 Nov; 25(49):8257-61. PubMed ID: 17964009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese encephalitis: new options for active immunization.
    Halstead SB; Thomas SJ
    Clin Infect Dis; 2010 Apr; 50(8):1155-64. PubMed ID: 20218889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A coverage evaluation survey of JE vaccination in two districts of Karnataka.
    Kumar KR; Basha R; Harish BR; Sanjay TV; Vinay M; Prabhu S; Babu R
    J Commun Dis; 2010 Sep; 42(3):179-84. PubMed ID: 22471181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological trends and characteristics of Japanese encephalitis changed based on the vaccination program between 1960 and 2013 in Guangxi Zhuang Autonomous Region, southern China.
    Yang Y; Liang N; Tan Y; Xie Z
    Int J Infect Dis; 2016 Apr; 45():135-8. PubMed ID: 26972041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese encephalitis in mainland china.
    Wang H; Li Y; Liang X; Liang G
    Jpn J Infect Dis; 2009 Sep; 62(5):331-6. PubMed ID: 19762980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese encephalitis: development of new candidate vaccines.
    Bharati K; Vrati S
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: using PRNT50 as an endpoint for immunogenicity.
    Reisler RB; Danner DK; Gibbs PH
    Vaccine; 2010 Mar; 28(12):2436-41. PubMed ID: 20060946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, attitudes and practices of caregivers regarding Japanese encephalitis in Shaanxi Province, China.
    Zhang S; Yin Z; Suraratdecha C; Liu X; Li Y; Hills S; Zhang K; Chen Y; Liang X
    Public Health; 2011 Feb; 125(2):79-83. PubMed ID: 21288546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
    Okamoto S; Yoshii H; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2008 Jan; 26(5):589-94. PubMed ID: 18180081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IC51 Japanese encephalitis vaccine.
    Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
    Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Japanese encephalitis in South Korea, 2007-2010.
    Lee DW; Choe YJ; Kim JH; Song KM; Cho H; Bae GR; Lee JK
    Int J Infect Dis; 2012 Jun; 16(6):e448-52. PubMed ID: 22497964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.